PharVision Advisers’s BlackRock TCP Capital TCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,177
Closed -$324K 588
2025
Q4
$324K Buy
+59,177
New +$341K 0.16% 231

Other funds holding TCPC

PharVision Advisers's TCPC Position: Q1 2026 in Review

PharVision Advisers sold out of BlackRock TCP Capital (TCPC) in Q1 2026, closing a stake of 59,177 shares — an estimated $324K sold.

PharVision Advisers first reported a position in TCPC in Q4 2025 and held it in 1 quarter. The position peaked at $324K in Q4 2025. 117 funds tracked by Wall St. Rank hold TCPC as of Q1 2026.

  • PharVision Advisers reported no remaining BlackRock TCP Capital position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 59,177 BlackRock TCP Capital shares in Q1 2026, an estimated $324K.
  • PharVision Advisers first reported a position in BlackRock TCP Capital in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's BlackRock TCP Capital position peaked at $324K in Q4 2025.
  • 117 funds tracked by Wall St. Rank held BlackRock TCP Capital as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.